Chemicals manufacturer Epigral Ltd has unveiled its inaugural research and development center in Ahmedabad, Gujarat, marking a significant investment of Rs. 30 crores. The company plans to continue investing in the facility to bolster its capabilities, according to an official statement.
Spread across 14,374 square meters, the newly launched research and development center is dedicated to advancing Epigral Ltd’s expertise in creating molecules for the production of pharmaceutical and agrochemical active ingredients. The center is expected to play a crucial role in fostering innovation within the company.
Epigral Ltd, previously known as Meghmani Finechem Ltd, has been a key player in the chemicals manufacturing sector since its incorporation in 2007. The company’s commitment to establishing a state-of-the-art R&D center aligns with its position as one of the leading integrated chemical manufacturers in India.
The Dahej, Gujarat plant is a testament to Epigral Ltd’s dedication to excellence in chemical manufacturing, and the new R&D center is poised to further elevate the company’s standing in the industry by driving innovation and advancements in the development of pharmaceutical and agrochemical products.
